Genmab Total Non-Operating Income/Expense 2019-2024 | GMAB
- Genmab annual total non-operating income/expense for 2023 was $0.046B, a 52.21% decline from 2022.
- Genmab annual total non-operating income/expense for 2022 was $0.096B, a 37.47% decline from 2021.
- Genmab annual total non-operating income/expense for 2021 was $0.154B, a 345.03% decline from 2020.